Results for: Psychedelics

Colorado has finalized comprehensive regulations for the emerging psilocybin industry, marking a significant step forward in the state’s pioneering efforts to legalize psychedelic therapy. The new rules, which were crafted over two years, provide a framework for businesses to operate in the production, distribution, and therapeutic use of psilocybin, DMT, ibogaine, mescaline, and psilocin, as approved by Proposition 122. This move positions Colorado as a leader in the growing movement to explore the therapeutic potential of psychedelics.

The HERO Act, signed into law by Massachusetts Governor Maura Healey, includes a provision to establish a psychedelics working group dedicated to investigating the potential therapeutic benefits of psilocybin and MDMA for veterans suffering from mental health conditions. This move highlights the growing interest in exploring alternative therapies for veterans’ mental health and the potential of psychedelics in treating conditions like PTSD.

Max Bell, a legendary music journalist and industry insider, shares his insights on the folk music scene, the transformative power of psychedelics, and the tumultuous career of Chuck Berry. Bell’s personal experiences and anecdotes provide a unique perspective on the changing landscape of rock and roll during the 1960s and 1970s.

The use of psychedelics to enhance work performance is gaining popularity in Silicon Valley, despite warnings from the FDA. Many believe that these substances can improve focus, creativity, and problem-solving abilities. While some proponents advocate for microdosing, others emphasize the need for more medical research.